Wells Fargo raises PT on US chemical firms
** Wells Fargo raises price target on chemical companies Avient Corp AVNT.N, Eastman Chemical Company EMN.N and Sherwin-Williams SHW.N
** Says that it remains positive on the chemicals sector as odds of a macro recovery over the next 12 months appear improved given U.S. Fed rate cuts and China stimulus; expects earnings growth to emerge as volumes recover in 2025
** Wells Fargo says that "we see commodity chemicals as the group which tends to outperform in the early stage of a recovery, with oil prices still firm and lower interest rates providing a needed tailwind"
Brokerage raises PT on the following firms:
Company | New PT | Old PT | Rating |
Avient Corp AVNT.N | $55 | $52 | Overweight |
Eastman Chemical Co EMN.N | $118 | $105 | Equal weight |
Sherwin-Williams Co SHW.N | $400 | $350 | Equal weight |
Reporting by Pooja Menon in Bengaluru
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
